Editor's Note The November 5 final report on data from this double-blind, randomized, placebo-controlled study of intravenous remdesivir in adults hospitalized with COVID-19 and lower respiratory tract infection shows that remdesivir was superior to placebo in shortening the time to recovery. A total of 1,062 patients were randomized to remdesivir…

Read More

Editor's Note Researchers from the University of Minnesota and M Health Fairview are using artificial intelligence (AI) to detect COVID-19 in chest x-rays of hospitalized patients. The researchers used 18,000 x-rays from COVID-19 patients and 100,000 x-rays from patients without the disease to develop and train an AI program to…

Read More

Preventing infection transmission has been a chief concern of healthcare leaders and staff striving to protect their patients and themselves from SARS-CoV-2, the virus that causes COVID-19. The virus poses an insidious threat that includes the possibility of bronchoscopy-associated transmission of COVID-19. Long before the pandemic, epidemiologist and researcher Cori…

Read More

Editor's Note This study led by researchers at the Massachusetts General Hospital and Harvard Medical School, Boston, finds that patients who survive serious COVID-19 infections have a long-lasting immune response against the virus. The study includes a cohort of case patients with known COVID-19 infection (343) and controls (1,548). Blood…

Read More

Editor's Note In this double-blind, randomized, placebo-controlled study of IV remdesivir in adults hospitalized with COVID-19 and lower respiratory tract infection, remdesivir was found to be superior to placebo in shortening the time to recovery. A total of 1,062 patients were randomized to either remdesivir (541) or placebo (521). Remdesivir…

Read More

Editor's Note New research presented October 12 at UEG [United European Gastroenterology] Week Virtual 2020 shows that delays in colorectal cancer (CRC) screening caused by COVID-19 has resulted in significantly increased mortality rates. Researchers at the University of Bologna, Italy, developed a model to forecast the impact of delayed CRC…

Read More

Editor's Note Leandro Pecchia, PhD, associate professor of biomedical engineering at the University of Warwick, Coventry, UK, has been awarded £13 million (nearly $17 million) for the ODIN project. The project will explore the use of robots and artificial intelligence (AI) to ease pressures on hospitals during recovery from COVID-19…

Read More

Editor's Note In this study, researchers from the University of Bristol in the UK, find that intubation and extubation of patients during general anesthesia may produce only a fraction of the aerosols previously thought, much less than that produced during a regular cough. The researchers conducted real-time, high-resolution environmental monitoring…

Read More

Editor's Note Preliminary findings in Moderna’s (Cambridge, Massachusetts) COVID-19 trial show the vaccine elicits strong immune system responses in older adults similar to responses in younger recipients, and adverse events associated with the vaccine are mainly mild or moderate. In its expansion to include older adults, the trial enrolled 40…

Read More

Editor's Note This study presented September 24 at the European Society of Clinical Microbiology and Infectious Diseases Conference on Coronavirus Disease finds that the initial SARS-CoV-2 viral load (VL) in nasopharyngeal samples has been decreasing as the pandemic progresses. The researchers from Wayne State University/Detroit Medical Center, Detroit, Michigan, also…

Read More